ArticleOncotarget2014

miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2.

Szu-Mam Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.